Active — Not RecruitingNot Applicable

The Analgesic Efficacy of Pecto-Intercostal Fascial Block Combined With Pectoral Nerve Block II Versus Serratus Plane Block in Modified Radical Mastectomy

Egypt70 participantsStarted 2025-10-15

Plain-language summary

The goal of this clinical trial is to to evaluate the analgesic efficacy of PECS II-PIFB versus SAPB for 24 hours in women aged from 18 to 65 years and scheduled for MRM. The main question it aims to answer is: which nerve block is better regarding the total analgesic consumption and the lowest postoperative complication

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for elective MRM * Age 18-65 years * American Society of Anesthesiologists (ASA) physical state I-II Exclusion Criteria: * Patient refusal. * Body Mass Index \> 30 kg/m2. * Skin infection at the site of injection. * History of renal, liver, cardiac, and neuropsychiatric disorder problems. * Bleeding or coagulation abnormality. * Known allergy to any drugs used in this study.

What they're measuring

The analgesic efficacy of PECS II-PIFB versus SAPB in patients scheduled for MRM by the total analgesic consumption (nalbuphine in mg) during the first 24 hours.

Timeframe: 24 hours

Trial details

NCT IDNCT07247448

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11

View on ClinicalTrials.gov More Pain Management trials